SCHEMBL26036727

SCHEMBL26036727

OC(CI)Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.48
CYP1A2 P05177 1/20 0.46
EPHX1 P07099 1/20 0.46
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
CASP1 P29466 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SRR Q9GZT4 2/20 0.44
ALPI P09923 1/20 0.43
PKM P14618 1/20 0.43
PTGS1 P23219 1/20 0.43
XIAP P98170 1/20 0.43
SLC7A5 Q01650 1/20 0.43
SLC6A2 P23975 2/20 0.43
TAAR1 Q96RJ0 2/20 0.43
MAOA P21397 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29033893 0.87 SRR (0.50) CYP1A2ALDH1A1SRRPTGS1TAAR1
SCHEMBL29033895 0.87 SRR (0.50) CYP1A2ALDH1A1SRRPTGS1TAAR1
SCHEMBL1833635 0.85 TRPA1 (0.55) TRPA1CYP1A2EPHX1SRRALPI
Ammonia Solution, Strong SCHEMBL29021310 0.82 TRPA1 (0.53) TRPA1CYP1A2EPHX1SRRALPI
SCHEMBL29061185 0.81 SRR (0.53) TRPA1CYP1A2EPHX1SRRALPI
SCHEMBL3091836 0.80 TRPA1 (0.52) TRPA1CYP1A2EPHX1SRRALPI
SCHEMBL5105980 0.80 TRPA1 (0.52) TRPA1CYP1A2EPHX1SRRALPI
SCHEMBL3091848 0.80 TRPA1 (0.52) TRPA1CYP1A2EPHX1SRRALPI
SCHEMBL25158 0.78 TRPA1 (0.56) TRPA1CYP1A2EPHX1SRRALPI
SCHEMBL2211027 0.78 TRPA1 (0.56) TRPA1CYP1A2EPHX1SRRALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed